Products

Products > Product Cytokines > IFN Beta 

IFN beta (Interferon beta)

Product Description:

  • Animal-derived product free
  • High Activity
  • Lyophilized and Carrier Free (CF)
  • Glycosylated

Xeno-free IFN betaHuXp (IFN beta 1/ IFN beta 1a), is a member of type I family of interferons. It binds to a heterodimeric receptor, known as the IFNα/β receptor (IFNAR) resulting in activation of a number of Jak/ STAT proteins. Activation of this signaling pathway results in activation of genes that inhibit viral infection and regulate MHC class I antigens. It is primarily produced by fibroblasts and monocytes. In addition to inhibiting viral infection, IFN beta is also involved in regulating and activating immune response against bacteria, parasite and tumor cells. Multiple sclerosis is characterized by a deficiency of IFN beta 1. An injectable form of IFN beta 1 is used for MS treatment.

Technical Specifications:

  • Species: Human
  • Expression: HEK293 Cell Expressed
  • Activity: Typically ≤ 0.1 ng/mL EC50
  • Purity: >95%
  • Endotoxin: <1 EU/μg
  • Molecular Mass: 18 to 22 kDa, glycosylated
  • Formulation: Sodium Acetate pH 4.8 + 150mM NaCl + CHAPS

Purity Confirmation:

The protein was resolved by SDS-polyacrylamide gel electrophoresis and the gel was stained with Coomassie blue.

Activity Assay:

The activity was determined by dose dependent inhibition of proliferation of TF-1 cells1.

Reconstitution Buffer:

Briefly centrifuge the vial before opening. It is recommended to reconstitute the protein in sterile water.

Synonyms: IFNbeta

Cat #: Size Price
HZ-1298 10 µg $226
HZ-1299 100 µg $882
HZ-1300 1000 µg $3,600

Human Cell Expressed

Animal Component-Free, Xeno-Free Production